$10.50 Per Share All-Cash Transaction Represents a Significant Premium for Tabula Rasa Stockholders
Combination of Two Highly Complementary Companies to Benefit Patients, Providers and Payers with.
Continued Strong Organic Revenue Growth of 24%
Second Quarter Adjusted EBITDA of $6.3 Million Increased More Than 3x Compared to Second Quarter 2022
MOORESTOWN, N.J., Aug. 7, 2023 /PRNewswire/ .